Search by Drug Name or NDC
NDC 68071-1650-05 Sulfacetamide Sodium and Prednisolone Sodium Phosphate 2.3; 100 mg/mL; mg/mL Details
Sulfacetamide Sodium and Prednisolone Sodium Phosphate 2.3; 100 mg/mL; mg/mL
Sulfacetamide Sodium and Prednisolone Sodium Phosphate is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by NuCare Pharmaceuticals,Inc.. The primary component is PREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM.
MedlinePlus Drug Summary
Ophthalmic prednisolone reduces the irritation, redness, burning, and swelling of eye inflammation caused by chemicals, heat, radiation, infection, allergy, or foreign bodies in the eye. It sometimes is used after eye surgery. Prednisolone is in a class of medications called steroids. It prevents swelling and redness by changing the way the immune system works.
Related Packages: 68071-1650-05Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Prednisolone Ophthalmic
Ophthalmic sulfacetamide stops the growth of bacteria that cause certain eye infections. It is used to treat eye infections and to prevent them after injuries.
Related Packages: 68071-1650-05Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Sulfacetamide Ophthalmic
Product Information
NDC | 68071-1650 |
---|---|
Product ID | 68071-1650_f8ada188-7c9f-0d4d-e053-6394a90ad11b |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Sulfacetamide Sodium and Prednisolone Sodium Phosphate |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Sulfacetamide Sodium and Prednisolone Sodium Phosphate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | SOLUTION/ DROPS |
Route | OPHTHALMIC |
Active Ingredient Strength | 2.3; 100 |
Active Ingredient Units | mg/mL; mg/mL |
Substance Name | PREDNISOLONE SODIUM PHOSPHATE; SULFACETAMIDE SODIUM |
Labeler Name | NuCare Pharmaceuticals,Inc. |
Pharmaceutical Class | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Sulfonamide Antibacterial [EPC], Sulfonamides [CS] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA074449 |
Listing Certified Through | 2024-12-31 |
Package
NDC 68071-1650-05 (68071165005)
NDC Package Code | 68071-1650-5 |
---|---|
Billing NDC | 68071165005 |
Package | 5 mL in 1 BOX (68071-1650-5) |
Marketing Start Date | 2019-03-05 |
NDC Exclude Flag | N |
Pricing Information | N/A |